Concepedia

Weekly Docetaxel in Elderly Patients with Prostate Cancer: Efficacy and Toxicity in Patients Aged ≥ 70 Years Compared with Patients Aged < 70 Years

Tomasz M. Beer, William R. Berry, Emily M. Wersinger, Lisa B. Bland

Clinical Prostate Cancer · 2003 · 50 citations · 14 references

DOI

Concepts

References

14

Cancer Statistics, 2003

Ahmedin Jemal, Thomas S. Murray, Alicia Samuels et al. · CA A Cancer Journal for Clinicians · 2003 · 3.3K citations · Full text

, , +17

Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials

Joy H. Lewis, Meredith L. Kilgore, Dana P. Goldman et al. · Journal of Clinical Oncology · 2003 · 1K citations

, , +15

Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

Diane Savarese, Susan Halabi, Vera Hárs et al. · Journal of Clinical Oncology · 2001 · 321 citations

, , +16

Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer

Harold J. Burstein, Judith Manola, Jerry Younger et al. · Journal of Clinical Oncology · 2000 · 261 citations

, , +16

Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results.

Joel Picus, Marcus J. Schultz · PubMed · 1999 · 245 citations

, , +10